10th Annual Oncology Innovation Forum

FOR BUSINESS DEVELOPMENT, LICENSING & INVESTMENT

31st of May 2024|Waldorf Astoria Chicago Hotel

Attendees:

3B Future Health Ventures

3E BioVentures

4C Biomed

7 Hills Pharma Inc.

AbbVie

AbbVie Ventures

Ability Pharmaceuticals

adMare BioInnovations

AdvantiGen LLC

Advent Life Sciences LLP

AIVITA Biomedical

Aleta Biotherapeutics

Allele Capital Partners

Amgen

Amplitude Ventures

Angiex

ApexOnco

Apollo Health Ventures

Aqua Partners LLC

Astellas Pharma

Astellas Venture Management LLC

AstraZeneca

ATEM Capital

ATHOS KG

Avego Biosciences Capital

Avstera Therapeutics Corp.

Bio Med Gene Ventures

Bioluminescence Ventures

Biosceptre (UK) Ltd.

BIOSTART Consulting GmbH

Biotech Venture Advisors S.r.l.

BiotechTV

Bloomberg Intelligence

Breakthrough Properties

Breslin AG

BTIG

BTIG LLC

Cancer Research Horizons

Cancer Research Institute

Capital Family Office

Capital Group

Carina Biotech Limited

CEF Insights

Corbus Pharmaceuticals Holdings

CU Innovations

Cullinan Therapeutics

Cumulus Oncology

Deca Ventures

DFB Pharmaceuticals

Edison Group

EF Hutton Group

Elicio Therapeutics

ESC Advisors

EsoBiotec

Ferghana Partners

Flagship Pioneering

Foghorn Therapeutics

FreeMind Group

Geneer Partners LLC

Geneos Therapeutics

Generation Fund Life Sciences Fund I

Gilead Sciences

Gritstone bio

Haley Titus Strategy

Hatch BioFund Management LLC

Health Innovation Capital

Heidelberg Pharma AG

Iaso Ventures

ICF Consult Switzerland

ICR Westwicke

ImmunoGenesis

ImmunoMet Therapeutics

Independent

Independent - KTM

Institute for Follicular Lymphoma Innovation

IPF Partners

Ipsos Healthcare Advisory Service

J.P. Morgan Life Sciences Private Capital

Jefferies International Ltd.

Jifeng Ventures

Johnson & Johnson

Johnson & Johnson Innovation LLC

Junson Capital

LanceBio Ventures

Lazard Ltd.

Lisata Therapeutics

Lumanity

Lumira Ventures

Medicenna Therapeutics Corp.

Mediqventures

Merck KGaA

Mianus Capital LLC

Moffitt Cancer Center

Moffitt Cancer Center Foundation

MPM BioImpact

MSQ Ventures

NanoCell Therapeutics

NanOlogy LLC

National Institutes of Health (NIH)

Novartis AG

Novatio Ventures

Nutcracker Therapeutics

NxR Biotechnologies GmbH

Oppenheimer & Co. Inc.

PDC Therapeutics SA

Pfizer

Pilatus Biosciences SA

PoC Capital

Portal Innovations

Prevail Partners LLC

Privos Capital

Promontory Therapeutics Inc.

QBiotics Group Limited

Quan Capital

RA Capital Management

Radiance Biopharma

Refined Science

Ryvu Therapeutics S.A.

Scancell Holdings PLC

Scandion Oncology A/S

Sensei Bio

Seventure Partners

Sherpa Healthcare Partners

Silicon Valley Bank

SIWA Therapeutics

Sound Bioventures Management AB

Stifel

Taiho Ventures

Takeda Ventures

Tamer Group

The Column Group

The Leukemia & Lymphoma Society

Theriva Biologics

UBS Securities

VCapital Management Co.

Vertex Ventures HC

Vista Capital Advisors

Vogel BioC

WBB Securities

Wellington Partners

Zai Lab Ltd.

Last updated: April 28, 2026